丹珍头痛胶囊联合疏肝调神针法对肝阳上亢型偏头痛患者临床疗效、疼痛症状改善、炎性因子、睡眠质量的影响

:-
 
目的 分析丹珍头痛胶囊联合疏肝调神针法治疗肝阳上亢型偏头痛患者的效果。方法 回顾性收集我院2023年8月~2025年4月148例肝阳上亢型偏头痛患者临床资料,依照治疗方案不同分为两组,各74例。对照组接受疏肝调神针法治疗,观察组接受丹珍头痛胶囊联合疏肝调神针法治疗,比较两组疗效、治疗前后临床症状[中医证候积分、发作情况(发作次数、持续时间、疼痛程度)]、睡眠质量[匹兹堡睡眠质量量表(PSQI)评分]、炎性相关因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、细胞间黏附分子-1(ICAM-1)、白细胞介素-10(IL-10)]水平、安全性(不良事件、不良反应)。结果 观察组总有效率较对照组高(P<0.05);治疗后,两组临床症状均减轻,且观察组中医证候积分较对照组低,发作次数较对照组少,持续时间较对照组短,疼痛程度较对照组低(P<0.05);治疗后,两组睡眠质量均提升,且观察组PSQI评分较对照组低(P<0.05);与治疗前相比,两组治疗后血清TNF-α、IL-6、ICAM-1均降低,IL-10均升高,且观察组优于对照组(P<0.05);两组治疗期间均未发生断针等不良事件及恶心呕吐等不良反应。结论 丹珍头痛胶囊联合疏肝调神针法治疗肝阳上亢型偏头痛患者,能有效改善临床症状,提高睡眠质量,调节炎性相关因子水平。
论著

重复经颅磁刺激应用于帕金森病失眠患者中的效果及对睡眠质量的影响研究

Effect of repetitive transcranial magnetic stimulation on Parkinson's patients with insomnia and its influence on sleep quality

:382-387
 
目的 探讨重复经颅磁刺激应用于帕金森病失眠患者中的效果及对睡眠质量的影响。方法 选取2021年1月—2022年3月南阳南石医院神经内科收治的帕金森病失眠患者100例,按照随机数字表法均分为参照组(n=50)和研究组(n=50),参照组采用常规西药治疗,研究组在参照组基础上采用重复经颅磁刺激治疗,对比两组治疗效果、神经递质指标水平、帕金森症状表现及睡眠质量评分的差异。结果 研究组治疗总有效率98.00%(49/50)高于参照组82.00%(41/50),对比差异有统计学意义(P<0.05)。治疗后,研究组神经递质多巴胺及5-羟色胺水平分别为(6.84±0.62)、(22.75±0.59),均高于参照组,对比差异均有统计学意义(P<0.05)。治疗后,研究组帕金森病症状表现及睡眠质量总评分均低于参照组,对比差异均有统计学意义(P<0.05)。结论 重复经颅磁刺激应用到帕金森病失眠患者的治疗中,能提升疗效,明显改善患者睡眠质量和帕金森病症状。
Objective To investigate the effect of repetitive transcranial magnetic stimulation(rTMS)on Parkinson's insomnia and its influence on sleep quality.Methods A total of 100 Parkinson's patients with insomnia admitted to the Department of Neurology,Nanyang Nanshi Hospital from January 2021 to March 2022 were selected and divided into the reference group(n=50)and the study group(n=50)according to random number table method.The reference group was treated with conventional western medicine,and the study group was treated with rTMS on the basis of the reference group.The levels of neurotransmitters,symptoms of Parkinson's disease and sleep quality were compared.Results The effective rate of the study group was 98.00%(49/50),which was higher than 82.00%(41/50)of the reference group,with statistical significance(P<0.05).After treatment,the levels of dopamine and 5-hydroxytryptamine in the study group,(6.84±0.62)and(22.75±0.59),were higher than those in the reference group,and the comparison was statistically significant(P<0.05).After treatment,the total score of Parkinson's symptom and sleep quality in the study group were lower than those in the reference group,with statistical significance(P<0.05).Conclusions The application of rTMS in the treatment of Parkinson's patients with insomnia can improve the curative effect,significantly improve the sleep quality and symptoms of Parkinson's disease,and is worthy of further application and promotion.
出版者信息








《广州医药》公众号